Doping control workflow solutions for Paris 2024 Olympic and Paralympic Games
Read our news article to learn more about doping control workflow solutions for Paris 2024 Olympic and Paralympic Games.
Read our news article to learn more about doping control workflow solutions for Paris 2024 Olympic and Paralympic Games.
Astrea Bioseparations, now part of Biotage. Read our news article to learn more about this strategic acquisition.
Biotage is the Global Go-To Separations Company, supporting customers from drug discovery and development through to diagnostics and analytical testing with intelligent and sustainable workflow solutions. Our expertise and top-tier separation solutions play a key role in streamlining our customers’ workflows and improving their outcomes. Headquartered in Sweden, Biotage operates globally with 700 employees, serving over 80 countries. Our company is listed on NASDAQ Stockholm (BIOT).
Copyright © 2024 Biotage